Skip to main content

Overview

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Abstract

This text is designed to support effective practices for clinicians, including physicians, nurse practitioners and cardiac nurse specialists, pharmacists, physician assistants, nutritionists, and others who treat high-risk African Americans. Pharmacologic therapy is usually necessary, but alone has not been sufficient to treat hypertension. Furthermore, the Institute of Medicine (IOM) has recognized five main environmental factors as prominent underpinnings for the widespread burden of hypertension in the United States [1]. Particular dietary patterns, nutrient intake, and levels and types of physical activity can play a major role in cardiovascular disease (CVD) prevention and treatment through effects on modifiable CVD risk factors (i.e., blood pressure [BP] and lipids). As it relates to hypertension in African Americans, the recent 2013 American College of Cardiology/American Heart Association (AHA/ACC) Guideline on Lifestyle Management to Reduce Cardiovascular Risk may be used to achieve appropriate BP prevention and control.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. A population-based policy and systems change approach to prevent and control hypertension. Report brief. Institute of Medicine. 2010. http://www.iom.edu/Reports/2010/A-Population-Based-Policy-and-Systems-Change-Approach-to-Prevent-and-Control-Hypertension.aspx. Accessed June 2014.

  2. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25_PA). doi:10.1016/j.jacc.2013.11.003.

  3. Scisney-Matlock M, Bosworth HB, Giger JN, Strickland OL, Harrison RV, Coverson D, et al. Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgrad Med. 2009;121(3):147–59.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Whitt-Glover MC, Hunter JC, Foy CG, Quandt SA, Vitolins MZ, Leng I, et al. Translating the Dietary Approaches to Stop Hypertension (DASH) diet for use in underresourced, urban African American communities, 2010. Prev Chronic Dis. 2013;10:120088.

    Article  PubMed  Google Scholar 

  5. Million Hearts® (MH). http://millionhearts.hhs.gov/index.html

  6. Ravenell J, Thompson H, Cole H, et al. A novel community-based study to address disparities in hypertension and colorectal cancer: a study protocol for a randomized control trial. Trials. 2013;14(1):287. and realizing another path to address health disparities.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60–9.

    Article  CAS  PubMed  Google Scholar 

  8. Roccella EJ, Horan MJ. The National High Blood Pressure Education Program: measuring progress and assessing its impact. Health Psychol. 1988;7(Suppl):297–303.

    Article  PubMed  Google Scholar 

  9. Saunders E, Kong BW. A role for churches in hypertension management. Urban Health. 1983;12(5):49–51, 55.

    CAS  PubMed  Google Scholar 

  10. Ferdinand KC. The Healthy Heart Community Prevention Project: a model for primary cardiovascular risk reduction in the African-American population. J Natl Med Assoc. 1995;87(8 Suppl):638–41.

    CAS  PubMed Central  PubMed  Google Scholar 

  11. Victor RG, Ravenell JE, Freeman A, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171(4):342–50.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary disease, stroke, and other cardiovascular diseases in the United States: findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000;102:3137–47.

    Article  CAS  PubMed  Google Scholar 

  13. Ayala C, Greenlund KJ, Croft JB, Keenan NL, Donehoo RS, Giles WH, et al. Racial/ethnic disparities in mortality by stroke subtype in the united states, 1995-1998. Am J Epidemiol. 2001;154:1057–63.

    Article  CAS  PubMed  Google Scholar 

  14. Kizer JR, Arnett DK, Bella JN, et al. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension. 2004;43:1182–8.

    Article  CAS  PubMed  Google Scholar 

  15. Okin PM, Kjeldsen SE, Dahlof B, Devereux RB. Racial differences in incident heart failure during antihypertensive therapy. Circ Cardiovasc Qual Outcomes. 2011;4:157–64.

    Article  PubMed  Google Scholar 

  16. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.

    Article  PubMed  Google Scholar 

  17. The booming dynamics of aging: from awareness to action. The white house conference on aging. Washington, DC: US Department of Health and Human Services; 2011.

    Google Scholar 

  18. Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey Jr DE, McMurray JJ, Drazner MH, Mitchell JE, Fonarow GC, Peterson PN, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:1495–539.

    Google Scholar 

  19. Shen AY, Contreras R, Sobnosky S, et al. Racial/ethnic differences in the prevalence of atrial fibrillation among older adults—a cross-sectional study. J Natl Med Assoc. 2010;102:906–13.

    PubMed  Google Scholar 

  20. Soliman EZ, Alonso A, Goff Jr DC. Atrial fibrillation and ethnicity: the known, the unknown and the paradox. Future Cardiol. 2009;5:547–56.

    Article  PubMed  Google Scholar 

  21. Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med. 2014;174(1):15–22. doi:10.1001/jamainternmed.2013.10522.

    Article  CAS  PubMed  Google Scholar 

  22. Ferdinand KC, Rodriguez F, Nasser SA, Caballero AE, Puckrein GA, Zangeneh F, et al. Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations. Cardiorenal Med. 2014;4:1–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Duprez DA, Jacobs Jr DR, Lutsey PL, et al. Race/ethnic and sex differences in large and small artery elasticity—results of the multi-ethnic study of atherosclerosis (MESA). Ethn Dis. 2009;19:243–50.

    PubMed Central  PubMed  Google Scholar 

  24. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. Hypertension. 2008;51(6):1403–19.

    Article  CAS  PubMed  Google Scholar 

  25. Ferdinand K, Nasser S. Improved understanding and innovative approaches for an aging dilemma: resistant hypertension in women with existing vascular disease. Curr Cardiovasc Risk Rep. 2012;6(5):450–8.

    Article  Google Scholar 

  26. Kandzari DE, Bhatt DL, Sobotka PA, O’Neill WW, Esler M, Flack JM, et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol. 2012;35(9):528–35.

    Article  PubMed  Google Scholar 

  27. Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens. 2012;6(2):152–8.

    Article  PubMed  Google Scholar 

  28. Schlaich MP, Schmieder RE, Bakris G, et al. International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol. 2013;62(22):2031–45.

    Article  PubMed  Google Scholar 

  29. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–53.

    Article  PubMed  Google Scholar 

  30. Go AS, Bauman M, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12):1230–8.

    Article  PubMed  Google Scholar 

  31. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella E; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.

    Google Scholar 

  32. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm Jr RH, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA. International Society on Hypertension in Blacks. Management of high blood pressure in blacks: an update of the international society on hypertension in blacks consensus statement. Hypertension. 2010;56:780–800.

    Article  CAS  PubMed  Google Scholar 

  33. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria C, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.

    Article  PubMed  Google Scholar 

  34. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith Jr SC, Watson K, Wilson PWF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;129(25 Suppl 2):S1–45.

    PubMed  Google Scholar 

  35. Wright Jr JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FHH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595–608.

    Article  CAS  PubMed  Google Scholar 

  36. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, Lefevre ML, Mackenzie TD, Ogedegbe O, Smith Jr SC, Svetkey LP, Taler SJ, Townsend RR, Wright Jr JT, Narva AS, Ortiz E. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. doi:10.1001/jama.2013.284427.

    Article  CAS  PubMed  Google Scholar 

  37. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend R, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension. J Hypertens. 2014;32(1):3–15. doi:10.1097/HJH.0000000000000065.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samar A. Nasser Ph.D., M.P.H., P.A.-C. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nasser, S.A. (2015). Overview. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_1

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics